Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes Mellitus
Status:
Withdrawn
Trial end date:
2021-07-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics, tolerability, and safety of
single and multiple doses of exenatide once-weekly suspension via subcutaneous (SC) injection
using a pre-filled, single-dose autoinjector in male and female Chinese with type 2 diabetes.